HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kouki Inai Selected Research

Carcinoma (Carcinomatosis)

2/2017Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma.
1/2017MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
2/2008Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry.
12/2007Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
12/2007Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer.
5/2006Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
1/2005Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma.
10/2004Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation.
9/2003Factors that influence the incidence of microscopic carcinoma in frozen and preserved specimens from patients with breast carcinoma after breast-conserving surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kouki Inai Research Topics

Disease

18Neoplasms (Cancer)
01/2022 - 04/2002
14Mesothelioma
03/2018 - 04/2005
9Carcinoma (Carcinomatosis)
02/2017 - 09/2003
7Lung Neoplasms (Lung Cancer)
08/2009 - 12/2004
6Adenocarcinoma
01/2022 - 05/2004
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2007 - 04/2002
4Hyperplasia
03/2018 - 01/2002
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2012 - 10/2005
4Adenocarcinoma of Lung
01/2012 - 04/2007
3Malignant Mesothelioma
09/2016 - 03/2012
3Carcinogenesis
08/2009 - 12/2004
2Breast Neoplasms (Breast Cancer)
10/2011 - 09/2003
2Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
01/2005 - 05/2004
1Pleural Effusion (Pleural Effusions)
09/2016
1Fibrosis (Cirrhosis)
03/2011
1Inflammation (Inflammations)
03/2011
1Asbestosis
03/2011
1Pneumothorax
08/2010
1Lung Diseases (Lung Disease)
12/2009
1Sarcoma (Soft Tissue Sarcoma)
02/2008
1Testicular Neoplasms (Testicular Cancer)
12/2007
1Leukemia
12/2007
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2006
1Neoplasm Metastasis (Metastasis)
05/2006
1Lymphatic Metastasis
05/2006
1AIDS-Related Complex (ARC)
04/2005
1Rhabdomyosarcoma
10/2004
1Chest Pain (Chest Pains)
10/2004
1Carcinosarcoma
10/2004
1Aphasia (Dysphasia)
10/2004
1Meningioma (Meningiomas)
06/2004
1Margins of Excision
09/2003

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
08/2017 - 09/2003
6AsbestosIBA
09/2016 - 04/2005
6Biomarkers (Surrogate Marker)IBA
01/2012 - 08/2006
4ParaffinIBA
01/2022 - 06/2010
4Calbindin 2IBA
01/2017 - 04/2005
4Complementary DNA (cDNA)IBA
11/2007 - 08/2006
3Formaldehyde (Formol)FDA Link
01/2022 - 01/2017
3Small Interfering RNA (siRNA)IBA
01/2013 - 11/2007
3Mucin-1 (CA 15-3 Antigen)IBA
02/2008 - 05/2003
3Keratins (Keratin)IBA
04/2007 - 04/2002
2RNA (Ribonucleic Acid)IBA
01/2022 - 08/2017
2SurvivinIBA
03/2018 - 06/2010
2Claudin-4IBA
02/2017 - 01/2017
2Monoclonal AntibodiesIBA
01/2012 - 12/2011
2AntibodiesIBA
12/2011 - 04/2007
2beta CateninIBA
08/2010 - 01/2005
2AntigensIBA
06/2010 - 12/2007
2CAM 5.2 antigenIBA
02/2008 - 04/2007
2VimentinIBA
04/2007 - 05/2003
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
08/2004 - 06/2004
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2017
1Messenger RNA (mRNA)IBA
08/2017
1SugarsIBA
01/2012
1Immunoglobulin G (IgG)IBA
01/2012
1Glycoproteins (Glycoprotein)IBA
12/2011
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
12/2011
1Secreted Frizzled-Related ProteinsIBA
08/2010
1DecitabineFDA Link
08/2010
1Caspase 3 (Caspase-3)IBA
06/2010
1SelectinsIBA
12/2009
1Oncogene Proteins (Oncogene Protein)IBA
08/2009
1Immunoglobulins (Immunoglobulin)IBA
08/2009
1Caveolin 1IBA
07/2009
1S100 Proteins (S 100 Protein)IBA
02/2008
1DesminIBA
02/2008
1antigen CYFRA21.1IBA
12/2007
1Tumor Biomarkers (Tumor Markers)IBA
12/2007
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
12/2007
1ThrombomodulinIBA
04/2007
1MesothelinIBA
04/2007
1Neurotensin Receptors (Neurotensin Receptor)IBA
10/2006
1Ghrelin ReceptorsIBA
10/2006
1neuromedin UIBA
10/2006
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2006
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
05/2006
1Vascular Endothelial Growth Factor CIBA
05/2006
1AmphiregulinIBA
10/2005
1Gefitinib (Iressa)FDA Link
10/2005
1Transforming Growth Factor alpha (TGF-alpha)IBA
10/2005
1DNA (Deoxyribonucleic Acid)IBA
06/2005
1MethyltransferasesIBA
06/2005
1Hyaluronic Acid (Hyaluronan)IBA
04/2005
1TalcFDA Link
04/2005
1Cadherins (E-Cadherin)IBA
01/2005
1Carcinoembryonic AntigenIBA
12/2004
1Cyclin-Dependent Kinase Inhibitor p16IBA
08/2004
1Proto-Oncogene Proteins c-mdm2IBA
06/2004
1Biological ProductsIBA
05/2004
1MucinsIBA
05/2004
1Glial Fibrillary Acidic ProteinIBA
05/2003

Therapy/Procedure

7Therapeutics
03/2012 - 12/2004
3Drug Therapy (Chemotherapy)
03/2012 - 09/2006
2Segmental Mastectomy (Lumpectomy)
10/2011 - 09/2003
2Lasers (Laser)
09/2006 - 08/2006
2Salpingo-oophorectomy
07/2004 - 04/2002
1Radiofrequency Ablation
10/2011
1Esophagectomy
10/2004
1Endoscopes
10/2004